Bank of New York Mellon’s Adeptus Health Inc ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-158,117
Closed -$284K 4430
2017
Q1
$284K Sell
158,117
-1,343
-0.8% -$7.54K ﹤0.01% 3768
2016
Q4
$1.22M Sell
159,460
-1,940,581
-92% -$35.7M ﹤0.01% 3146
2016
Q3
$90.4M Buy
2,100,041
+1,043,115
+99% +$47.1M 0.03% 582
2016
Q2
$54.6M Buy
1,056,926
+912,873
+634% +$54.7M 0.02% 804
2016
Q1
$8M Buy
144,053
+1,236
+0.9% +$63.9K ﹤0.01% 1958
2015
Q4
$7.79M Buy
142,817
+78,812
+123% +$5.03M ﹤0.01% 1980
2015
Q3
$5.17M Buy
64,005
+25,189
+65% +$2.6M ﹤0.01% 2209
2015
Q2
$3.69M Buy
38,816
+8,426
+28% +$580K ﹤0.01% 2549
2015
Q1
$1.53M Sell
30,390
-17,513
-37% -$693K ﹤0.01% 3047
2014
Q4
$1.79M Buy
47,903
+29,282
+157% +$922K ﹤0.01% 2941
2014
Q3
$464K Buy
+18,621
New +$486K ﹤0.01% 3658

Other funds holding ADPT

Bank of New York Mellon's ADPT Position: Q2 2017 in Review

Bank of New York Mellon sold out of Adeptus Health Inc (ADPT) in Q2 2017, closing a stake of 158,117 shares — an estimated $284K sold.

Bank of New York Mellon first reported a position in ADPT in Q3 2014 and held it in 11 quarters. The position peaked at $90.4M in Q3 2016. 9 funds tracked by Wall St. Rank hold ADPT as of Q2 2017.

  • Bank of New York Mellon reported no remaining Adeptus Health Inc position as of Q2 2017 after selling out during the quarter.
  • Bank of New York Mellon sold 158,117 Adeptus Health Inc shares in Q2 2017, an estimated $284K.
  • Bank of New York Mellon first reported a position in Adeptus Health Inc in Q3 2014 and held it in 11 quarters.
  • Bank of New York Mellon's Adeptus Health Inc position peaked at $90.4M in Q3 2016.
  • 9 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q2 2017.

Based on Bank of New York Mellon's 13F filing for Q2 2017, filed 3 Aug 2017.